A SaaS^? platform that aggregates real-time data from FDA databases, ClinicalTrials.gov, CMS coverage decisions, patent filings, and press releases. It provides customizable dashboards tracking KPIs^? like trial enrollment rates, regulatory submission timelines, partnership developments, reimbursement status, and commercial adoption metrics (kits sold, turnaround times, reorder rates). Users receive AI-powered alerts on material milestones and can benchmark companies against competitors.

The non-invasive colorectal cancer screening market is reaching an inflection point in 2025-2026 with multiple players (Shield, Cologuard Plus, ColoAlert) launching pivotal trials and seeking FDA approval. Defined regulatory timelines and heated competition make real-time intelligence critical for timely investment decisions.